Canada markets open in 6 hours 9 minutes
  • S&P/TSX

    18,457.78
    +76.82 (+0.42%)
     
  • S&P 500

    3,821.35
    -20.59 (-0.54%)
     
  • DOW

    31,802.44
    +306.14 (+0.97%)
     
  • CAD/USD

    0.7905
    +0.0006 (+0.08%)
     
  • CRUDE OIL

    64.85
    -0.20 (-0.31%)
     
  • BTC-CAD

    67,954.16
    +4,342.05 (+6.83%)
     
  • CMC Crypto 200

    1,082.55
    +58.35 (+5.70%)
     
  • GOLD FUTURES

    1,692.90
    +14.90 (+0.89%)
     
  • RUSSELL 2000

    2,202.98
    +10.77 (+0.49%)
     
  • 10-Yr Bond

    1.5960
    0.0000 (0.00%)
     
  • NASDAQ futures

    12,493.25
    +196.00 (+1.59%)
     
  • VOLATILITY

    25.47
    +0.81 (+3.28%)
     
  • FTSE

    6,700.90
    -18.23 (-0.27%)
     
  • NIKKEI 225

    29,027.94
    +284.69 (+0.99%)
     
  • CAD/EUR

    0.6652
    -0.0010 (-0.15%)
     

Theratechnologies to Present at the B. Riley Securities Virtual Oncology Investor Conference

Theratechnologies
·1 min read

MONTREAL, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Paul Levesque, President and Chief Executive Officer and Dr. Christian Marsolais, Senior Vice President and Chief Medical Officer will present at the B. Riley Virtual Oncology Investor Conference on Wednesday, January 20, 2021 at 3:30 p.m. ET.

To access the live virtual presentation, please visit the ‘News’ section of the Company’s website. A webcast replay will also be available approximately two hours after the presentation.

About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.

For media inquiries:
Denis Boucher
Vice-President, Communications and Corporate Affairs
514-336-7800

For investor inquiries:
Leah Gibson
Senior Director, Investor Relations
lgibson@theratech.com
617-356-1009